Raphas
Seoul · Founded 2006
About Raphas
Despite a long history of research efforts on the subject, skin-based drug delivery techniques often cannot effectively permeate the skin barrier, with research limited to only a handful of drugs. Raphas has overcome this limitation by developing an innovative drug delivery system that enables everyone to painlessly and conveniently apply the patch on their own. Their technology can be employed in various fields, where delivery of active ingredients is required, from cosmetics to medicine. Raphas is a global company that utilizes world-class technologies while continually exploring ways of improving people’s health in order to create products that ensure their happiness.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Last round: Series Unknown (Jan 2010)
- Website: raphas.com
- Phone: 82-2-392-3011
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/raphas-3130949 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.